NASDAQ: EYPT       Eyepoint Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
10.44   +0.24 (2.35%)  10.23 - 10.57  43,375


Avg Volume (4 weeks):114,190
4 Weeks Range:8.70 - 12.57
4 Weeks Price Volatility (%):
52 Weeks Range:7.30 - 14.98
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

EyePoint Pharmaceuticals Inc, formerly pSivida Corp is a US-based specialty pharmaceutical company which is engaged in developing sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. The company has developed three sustained-release products for the treatment of back-of-the-eye diseases. The lead product candidate is Durasert which is designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye for three years from a single injection. The company's development program is focused primarily on utilizing two core technology platforms to deliver drugs and biologics to treat chronic diseases.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

5716  3700  1209  1665 

Top 10 Active Counters
 IMPP 0.48-0.285 
 TQQQ 32.69+2.04 
 ISBC 13.87-0.35 
 SNDL 0.44-0.025 
 SQQQ 50.34-3.71 
 MKD 0.15+0.034 
 AMD 101.58+7.34 
 AUVI 1.30+0.26 
 NLY 6.455-0.235 
 NIO 16.27+1.72